Testing, calibration and advisory services provider, Exova, has acquired SL Pharma, a US-based pharmaceutical business.
SL Pharma provides pharmaceutical Chemistry, Manufacturing and Controls (CMC) product development and quality control testing services, focused primarily on parenteral, ophthalmic, intranasal and topical drug products
The business supports clients in North America, Australia, Europe and Japan to gain regulatory approvals and meet commercial timelines and budgetary requirements.
James Scull, Vice President, Health Sciences Americas, said: “The addition of SL Pharma is a demonstration of our expanding testing capabilities to meet CMC product development.”
Waheed Sheikh, President, SL Pharma, said: “Becoming part of a global testing and advisory business is a great move for SL Pharma and our customers as it gives us access to new capabilities and expertise.”
